For Difficult Cases · The Inter-Specialty White Space Engine · Root-Cause Resolution

When no one can tell you
what is wrong.

Some cases don’t fit. The symptoms cross specialties, the tests come back “unremarkable,” and every referral restarts the story from page one. This page is honest about why that happens (it is a structural problem, not your doctors’ failure) and what changes the moment your physician is equipped with DeepSensi™: one doctor at your side, wielding the diagnostic power of an entire university hospital.

What DeepSensi™ means for patients Write to us

A difficult case laid out on one large white table, seen from above at an angle: laboratory printouts, two imaging films on a slim lightbox, handwritten notes from different clinics,…

~5 yrs

average rare-disease diagnostic journey in Europe (EURORDIS survey data)

Every

discipline of medicine, seated at one table

12 s: 3 min

for a full consilium deliberation, versus the days a human panel takes to convene

The odyssey is real

Years. Many specialists. No answer.

A patient's thick ring binder open on a home dining table: years of results in plastic sleeves, sticky notes along the edge, a paper calendar with many appointments circled. A cup and…

The numbers behind the frustration

Patient organisations have measured what families live: across Europe, the average journey to a rare-disease diagnosis runs to about five years (EURORDIS Rare Barometer), through repeated referrals and not-quite-wrong diagnoses. Difficult cases are rare one at a time, and common in aggregate.

It is not your doctor’s failure

Medicine holds more than a single mind can: thousands of conditions, tens of thousands of interactions, literature that doubles faster than any career. A physician seeing thirty patients a day is not under-trained. They are under-resourced against complexity. That is an architecture problem.

Referrals are serial. Your case is parallel.

The referral chain interrogates one organ system at a time, each specialist seeing a fragment. A cross-cutting disease lives exactly in the gaps between those fragments, which is why it survives so many good doctors.

What a consilium changes

Every discipline at the table. At once.

For the hardest cases, medicine’s answer has always been the consilium: many specialists deliberating together. It works; it just doesn’t scale: assembling one takes days, so it is reserved for the very few. DeepSensi™ makes that deliberation the default: a specialist counterpart for every discipline of medicine, arguing your case in parallel, upon evaluation.

A consilium seen from high above: five specialists seated around a pale round table with papers and tablets, all looking at one case shown as an abstract layout on a wall display. Bright…

It finds. Your physician verifies and signs.

In a truly difficult case the physician does not yet have the answer. That is what makes it difficult. DeepSensi™ is how they get it, with proof: the consilium derives the diagnosis and shows its full reasoning; your physician verifies that conclusion against you (history, context, the whole person) and signs it. The finding power is the machine’s; verification and accountability stay human, and the signature never stands alone: every step of the deliberation is cryptographically sealed in an immutable, court-grade audit ledger (Patent Pending), so the decision carries its full evidence with it.

It says “I don’t know”

A structured uncertainty protocol (LIMBO) makes honest doubt a first-class answer, and Active Sensing names the single test that would most decisively resolve an ambiguous case, often the most valuable sentence in a difficult workup.

It is calibrated to never miss quietly

In development testing on 301 of the hardest published cases (NEJM Clinicopathological Conferences), safety-first calibration sharply reduced missed-critical findings at a cost of 2.3 seconds of median deliberation. Development-cohort results; the prospective study is announced and pre-registered. The science →

Trials & public benefit allocation

Golden Horizon provides subsidized access to our Precision Medicine Suites (up to 10,000 cases subsidized annually under the DeepSensi PBC Charter, including 100% full hardship fee waivers for the most in-need, with patients bringing their own locally performed diagnostic tests) and matches patients to clinical trials and public benefit allocation programs.

What you can do today

Three questions worth asking.

Ask your hospital

Ask whether your hospital or clinic runs DSS-certified clinical decision support: certification against an open, royalty-free safety standard (DSS-001) that any institution can verify. Institutions adopt what patients ask for by name.

Hospital Diagnostic Accuracy Study (SILENT-DS™)

Hospitals join the SILENT-DS™ multicenter study to measure diagnostic yield where diagnostic dead-ends are most common: in complex patient cohorts. Details for clinics →

Use your right to a second opinion

In most health systems a second opinion is your right, not a favour. A difficult case deserves a second set of minds: human ones today, and a full consilium where the infrastructure exists.

Write to us, patient enquiry For patients

DeepSensi™ operates as an institutional Cognitive Engine and Difficult Cases Engine deployed in collaboration with licensed clinicians and healthcare institutions. All diagnostic conclusions are delivered as fully auditable, multidisciplinary clinical consilium dossiers to empower treating physicians with definitive diagnostic clarity. Emergency services note: For acute emergencies, contact local emergency services immediately.

A patient and a close companion walk away from the camera down a bright hospital corridor towards a tall window, the companion's hand lightly on her shoulder. Ultra-wide frame, soft…

Questions

Asked by patients and families.

Does DeepSensi™ diagnose my case directly?

DeepSensi diagnoses the case decisively as an institutional clinical consilium. Its results on 301 of the hardest published cases in medicine (NEJM CPC) are on our Science page. Your treating physician reviews the multi-specialty consilium dossier, verifies the reasoning against your full history, and signs the clinical orders. Every conclusion is backed by an unbroken evidentiary chain and an immutable, court-grade audit ledger, ensuring your doctor signs verified clinical proof, never a black-box guess.

How can patients and families access the Difficult Cases Engine?

Patients and families can access the platform through their treating physician, our dedicated Precision Medicine Suites, or by enrolling in one of our 9 global clinical registries (such as EPI-RESOLVE for drug-resistant epilepsy). If you or a family member are trapped in an unresolved medical odyssey, your physician can submit a case profile with direct identifiers removed to run an immediate multi-disciplinary consilium in approximately 2 minutes.

Why do complex diseases fall into the “Inter-Specialty White Space”?

Structure, not physician competence. Healthcare is fragmented into isolated clinical specialties: a neurologist evaluates seizures, an immunologist inflammation, a gastroenterologist the gut, and a geneticist isolated mutations. But complex, refractory diseases live in the metabolic, toxicological, and neuro-immune interactions between these systems: the White Space. DeepSensi integrates multi-omic data (WGS, organic acids, microbiome toxins, pharmacokinetics) into an unified tensor, uncovering the root causes connecting disparate symptoms where siloed specialists found only dead ends.

What is the mechanism behind safety-first calibration?

Across 301 of the hardest published NEJM Clinicopathological Conference cases, DeepSensi’s Gomola Framework dual-engine safety architecture and the LIMBO protocol drove missed critical findings down; the figures are on our Science page. When clinical evidence is incomplete or ambiguous, the system strictly refuses to guess: it identifies the single decisive diagnostic test or biomarker needed to settle the case and alerts senior clinical oversight.

Is clinical trial matching and registry access available?

Yes. Under our core mission, clinical registry access and clinical trial matching are engineered for rapid accessibility: if a targeted trial, compassionate use program, or novel therapeutic pathway exists for your condition, finding it should never be a barrier for a patient who is suffering. Requires FDA authorizationNot available in your region yet

Science

Scientific FoundationDigital Nemawashi™ & consensus logic WhitepapersWhitepapers published on Zenodo with DOI Evaluating Medical AI301 NEJM CPC diagnostic benchmark Difficult Diagnostic CasesComplex case clinical dossiers

When no one can tell youwhat is wrong.